Home » Topics » Regulatory

Regulatory
RSS

First anti-TNF agent approved for ankylosing spondylitis in E.U.

May 22, 2003

Remicade approved in E.U. for maintenance therapy in Crohn's disease

May 22, 2003

Diabact licenses Rapinyl to Kyowa Hakko

May 20, 2003

FDA committee recommends Valtrex for reduction of genital herpes transmission

May 19, 2003

Launch of Klonopin Wafers

May 16, 2003

Completely new approach to cancer treatment given the go-ahead by the FDA for multiple myeloma

May 15, 2003

3M submits Aldara sNDA for actinic keratosis

May 14, 2003

FDA approves revised labeling for Flonase

May 14, 2003

Adderall XR program in adolescents to extend marketing exclusivity

May 13, 2003

FDA approves new flexible dosing regimen for Lantus

May 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...